Insmed Incorporated
INSM
$70.20
-$0.87-1.22%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 363.71M | 342.96M | 328.61M | 315.49M | 305.21M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 363.71M | 342.96M | 328.61M | 315.49M | 305.21M |
| Cost of Revenue | 85.74M | 78.03M | 73.57M | 69.20M | 65.57M |
| Gross Profit | 277.97M | 264.92M | 255.04M | 246.29M | 239.64M |
| SG&A Expenses | 461.12M | 408.13M | 379.83M | 357.69M | 344.50M |
| Depreciation & Amortization | 5.05M | 5.05M | 5.05M | 5.05M | 5.05M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.15B | 1.05B | 972.46M | 996.17M | 986.14M |
| Operating Income | -786.57M | -703.93M | -643.85M | -680.68M | -680.93M |
| Income Before Tax | -910.07M | -860.85M | -799.73M | -744.23M | -747.01M |
| Income Tax Expenses | 3.71M | 3.44M | 2.97M | 2.66M | 2.56M |
| Earnings from Continuing Operations | -913.77 | -864.29 | -802.69 | -746.89 | -749.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -913.77M | -864.29M | -802.69M | -746.89M | -749.57M |
| EBIT | -786.57M | -703.93M | -643.85M | -680.68M | -680.93M |
| EBITDA | -777.70M | -695.06M | -634.95M | -671.90M | -672.49M |
| EPS Basic | -5.59 | -5.56 | -5.40 | -5.24 | -5.35 |
| Normalized Basic EPS | -3.11 | -2.97 | -2.89 | -3.14 | -3.21 |
| EPS Diluted | -5.59 | -5.56 | -5.40 | -5.24 | -5.35 |
| Normalized Diluted EPS | -3.11 | -2.97 | -2.89 | -3.14 | -3.21 |
| Average Basic Shares Outstanding | 655.90M | 621.69M | 590.86M | 573.71M | 561.61M |
| Average Diluted Shares Outstanding | 655.90M | 621.69M | 590.86M | 573.71M | 561.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |